Akero Therapeutics (AKRO) PT Lowered to $84 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Michael Ulz lowered the price target on Akero Therapeutics (NASDAQ: AKRO) to $84.00 (from $90.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
